Back to News
Market Impact: 0.3
Disc Medicine Launches $350M Stock Offering Following Positive Phase 3 Results
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Disc Medicine announced a proposed underwritten public offering of $350 million of common stock and, for certain investors, pre-funded warrants to purchase common stock. The article does not specify the offering price, use of proceeds, or expected closing date.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
IRON-0.20
More News
- Disc Medicine prices $450 million stock offering at $75/share
- Australian data center operator NextDC's shares plunge 40% after it slashes earnings forecast
- Elon Musk says Tesla and SpaceX are weighing a $3.5 trillion merger—without him in the room
- Neoclouds Lose Silver Lining as Elice, CoreWeave Dive: Evening Briefing Americas
- Anthropic May Spend $750 Billion on Computing Costs, WSJ Reports
- This Janus Henderson fund manager owns CoreWeave debt — here's why he's sticking with it